NFLX showing signs of strength as it breaks out from descending wedge.
Chart says it all. Target 315-320. Then we short the heck out of it.
Taking a long on $eman looking for a trend reversal. Slightly aggressive on the entry. One can wait for a 4hr or daily trend change if desired. I defined my risk based on the 2 hr chart. TP levels indicated.
AMD has been on a crazy trend since October and with the China Trade Deal will 5G and other Chip maker take off? I usually sell when the 6 month RSI reaches 70.00. I'm going long to 47
RSI divergence is telling us there may be a retracement coming in the near future, so be careful adding a new bullish position. I'm long-term bullish on NASDAQ:ACLS , but a short-term short play might be wise. Strongest support is currently at $22.75, $22.00, and $20.50.
Ticker: $QQQ QQQ is clearly weekly than SPY, IWM, XLF, and XLV. QQQ is not close to ATH resistance of 206.05 whereas the other sectors are near ATH or broke daily resistance. If the market pulls back, QQQ will set a daily lower high compared to 206.06 and I expect an equilibrium. If markets are strong, I will watch to see if QQQ could break 266.05 to add fuel...
It is anticipated that around 60% of the float is now locked and the rest to be locked by hedge funds and whales who will be coming in before the filings for the merger drops. The merging in candidate following all the DD is said to be RockySaaS, owned by $10 Bil Panshi Group. There is much much more DD in the iHub stickies than can be inputted...
Now, generally, I think giga-shorting indices as they push all-time-highs every single day is a bad idea. Trends shall remain irrational longer than you can remain solvent, the Federal Reserve is incessantly printing away your purchasing power which means there's more money to pump your stonks, and trends, namely the centuries-long bull trend, have been so...
Sell signal at 50.06 $ Timeframe - 1 week. Cognex Corporation ( Cognex ) is a provider of machine vision products that capture and analyze visual information in order to automate tasks, primarily in manufacturing processes, where vision is required. ATTENTION this strategy may has downtrend about 20%, so you can split your buy order, that you have not big...
Higher timeframe bullish trend Higher timeframe MA support Impulse, correction in form of flag, buy the continuation Breakout and retest of descending channel on the hourly with MA support Target outer structure
BLCM has been in continuous long-term downtrend since IPO. Stock price has been showing signs of a bo... Click here to read the rest of my analysis on BLCM. Disclosure: I am long BLCM. This is not a recommendation to buy/sell as I am NOT a financial advisor. Please do your homework before investing.
Quick one on QQQ today, as you can see we are a hair away from the 1.272 fib projection ($199.42) from the prior move up (beginning in 2008 at the lows to the swing high/ low in 2015). Will this act as resistance? I would think so, we may have a few more positive days, but these fib levels typically act as quite substantial resistance, this is ignoring the clear...
This stock has suffered over the past 12 months, but made a nice recovery after a less than stellar e/r. Looking like a standard C&H. Break over the neckline and we may see a breakout, backtest, jump.
Twilio looks oversold and ready to bounce towards the 200 day average. May re-test that lower trendline as well. Long here with tight stop. Short at or above the 200 with a similarly tight stop. Set trailing stop once the descent is confirmed with 2 red daily candles.
As the "Trade Deal - Phase One" between the US and China comes into fruition, this piece of news could not have come at a better time for the Nasdaq ($IXIC). With the Nasdaq brushing up against it's Monthly Resistance Level of 7879.50 (Blue Line), in the midst of an uptrend, the news of a Trade Deal between two economic giants may act as a much needed tailwind to...
Friday, October 11, 2019 ADVM is a clinical-stage gene therapy company targeting unmet medical needs in ocular and rare diseases, ADVM is set to present additional clinical data for the first cohort of patients (n=6) in the OPTIC phase 1 clinical trial of ADVM-022, intra-vitreal injection gene therapy in wet age-related macular degeneration (wet AMD) at the...
Buy Bango (BGO.L) Bango PLC (Bango) offers the Bango mobile payment platform. The Company's principal activity is the development, marketing and sale of technology to enable mobile phone users to make payments for digital content and media on smartphones and tablets. The Company's segments include End user activity and Platform fees. The End user activity segment...